This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Audit, M.
Right arrow Articles by Sitbon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audit, M.
Right arrow Articles by Sitbon, M.

 Previous Article  |  Next Article 

Journal of Virology, December 1999, p. 10472-10479, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Introduction of a cis-Acting Mutation in the Capsid-Coding Gene of Moloney Murine Leukemia Virus Extends Its Leukemogenic Properties

Muriel Audit,1 Jérôme Déjardin,1 Barbara Hohl,2 Christine Sidobre,1 Thomas J. Hope,2 Marylène Mougel,1 and Marc Sitbon1,*

Institut de Génétique Moléculaire de Montpellier (IGMM), IFR24, CNRS-UMR5535, and Université Montpellier II, F-34293 Montpellier Cedex 5, France,1 and Infectious Disease Laboratory, The Salk Institute for Biological Studies, La Jolla, California 920372

Received 21 May 1999/Accepted 8 September 1999

Inoculation of newborn mice with the retrovirus Moloney murine leukemia virus (MuLV) results in the exclusive development of T lymphomas with gross thymic enlargement. The T-cell leukemogenic property of Moloney MuLV has been mapped to the U3 enhancer region of the viral promoter. However, we now describe a mutant Moloney MuLV which can induce the rapid development of a uniquely broad panel of leukemic cell types. This mutant Moloney MuLV with synonymous differences (MSD1) was obtained by introduction of nucleotide substitutions at positions 1598, 1599, and 1601 in the capsid gene which maintained the wild-type (WT) coding potential. Leukemias were observed in all MSD1-inoculated animals after a latency period that was shorter than or similar to that of WT Moloney MuLV. Importantly, though, only 56% of MSD1-induced leukemias demonstrated the characteristic thymoma phenotype observed in all WT Moloney MuLV leukemias. The remainder of MSD1-inoculated animals presented either with bona fide clonal erythroid or myelomonocytic leukemias or, alternatively, with other severe erythroid and unidentified disorders. Amplification and sequencing of U3 and capsid-coding regions showed that the inoculated parental MSD1 sequences were conserved in the leukemic spleens. This is the first report of a replication-competent MuLV lacking oncogenes which can rapidly lead to the development of such a broad range of leukemic cell types. Moreover, the ability of MSD1 to transform erythroid and myelomonocytic lineages is not due to changes in the U3 viral enhancer region but rather is the result of a cis-acting effect of the capsid-coding gag sequence.

* Corresponding author. Mailing address: Institut de Génétique Moléculaire de Montpellier (IGMM), IFR24, CNRS-UMR5535, Université Montpellier II, 1919 Rte de Mende, F-34293 Montpellier Cedex 5, France. Phone: 33 (4)67 61 36 40. Fax: 33 (4)67 04 02 31. E-mail: sitbon{at}igm.cnrs-mop.fr.

Journal of Virology, December 1999, p. 10472-10479, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Hardenberg, G., Fernandez, L., Hendriks, J., Chebli, K., Jacquet, C., Sitbon, M., Hahne, M., Medema, J. P. (2008). APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. J. Leukoc. Biol. 84: 380-388 [Abstract] [Full Text]  
  • Maurel, S., Houzet, L., Garcia, E. L., Telesnitsky, A., Mougel, M. (2007). Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing. RNA 13: 2266-2276 [Abstract] [Full Text]  
  • Rodenburg, M., Fischer, M., Engelmann, A., Harbers, S. O., Ziegler, M., Lohler, J., Stocking, C. (2007). Importance of Receptor Usage, Fli1 Activation, and Mouse Strain for the Stem Cell Specificity of 10A1 Murine Leukemia Virus Leukemogenicity. J. Virol. 81: 732-742 [Abstract] [Full Text]  
  • Kim, F. J., Manel, N., Boublik, Y., Battini, J.-L., Sitbon, M. (2002). Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation Can Be Activated in Resistant Mammalian Cell Lines by a Carboxy-Terminal Truncation of the Envelope Cytoplasmic Domain. J. Virol. 77: 963-969 [Abstract] [Full Text]  
  • Déjardin, J., Bompard-Maréchal, G., Audit, M., Hope, T. J., Sitbon, M., Mougel, M. (2000). A Novel Subgenomic Murine Leukemia Virus RNA Transcript Results from Alternative Splicing. J. Virol. 74: 3709-3714 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»